Literature DB >> 16266940

Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances.

Alan Wayne Jones1.   

Abstract

OBJECTIVE: This article describes the background and implementation in Sweden of zero-concentration limits for controlled drugs in the blood of drivers. Eliminating the need to prove that a person's ability to drive safely was impaired by drugs has greatly simplified the prosecution case, which now rests primarily on the forensic toxicology report. Driving under the influence of a prescription drug listed as a controlled substance is exempt from the zero-limit law provided the medication was being used in accordance with a physician's direction and the person was not considered unfit to drive.
METHODS: The prevalence of driving under the influence of drugs (DUID) in Sweden was evaluated from police reports with the main focus on the toxicological findings. A large case series of DUID suspects was compared before and after introducing zero concentration limits in blood for controlled substances on July 1, 1999. The spectrum of drugs used by typical offenders and the concentrations of various licit and illicit substances in blood were evaluated and compared.
RESULTS: Immediately after the zero-limit law came into force, the number of cases of DUID submitted by the police for toxicological analysis increased sharply and is currently ten-fold higher than before the new legislation. Statistics show that about 85% of all blood samples sent for toxicological analysis have one or more banned substances present. Amphetamine is by far the leading drug of abuse in Sweden and was identified in about 50-60% of all DUID suspects either alone or together with other controlled substances. The next most frequently encountered illicit drug was tetrahydrocannabinol (THC), with positive findings in about 20-25% of cases. Various prescription drugs, mainly sedative-hypnotics like diazepam and flunitrazepam, were also highly prevalent and these occurred mostly together with illicit substances. Opiates, such as 6-acetyl morphine and morphine, the metabolites of heroin, were high on the list of substances identified. Most DUID suspects in Sweden were men (85%) who were poly-drug users combining illicit substances, like amphetamine and/or cannabis, with a prescription medication such as various benzodiazepines.
CONCLUSIONS: Sweden's zero-concentration limit has done nothing to reduce DUID or deter the typical offender because recidivism is high in this population of individuals (40-50%). Indeed, many traffic delinquents in Sweden are criminal elements in society with previous convictions for drunk and/or drugged driving as well as other offenses. The spectrum of drugs identified in blood samples from DUID suspects has not changed much since the zero-limit law was introduced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16266940     DOI: 10.1080/15389580500253760

Source DB:  PubMed          Journal:  Traffic Inj Prev        ISSN: 1538-9588            Impact factor:   1.491


  5 in total

1.  Effects of d-amphetamine on simulated driving performance before and after sleep deprivation.

Authors:  Magnus Hjälmdahl; Anna Vadeby; Asa Forsman; Carina Fors; Gunnel Ceder; Per Woxler; Robert Kronstrand
Journal:  Psychopharmacology (Berl)       Date:  2012-05-26       Impact factor: 4.530

Review 2.  Potentially Driver-Impairing Medications: Risks and Strategies for Injury Prevention.

Authors:  Timothy Ivers; Nicole D White
Journal:  Am J Lifestyle Med       Date:  2016-01-13

Review 3.  The relationship between benzodiazepine use and traffic accidents: A systematic literature review.

Authors:  Beitske E Smink; Antoine C G Egberts; Klaas J Lusthof; Donald R A Uges; Johan J de Gier
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

4.  Driving under the influence of gamma-hydroxybutyrate (GHB).

Authors:  Alan Wayne Jones; Anita Holmgren; Fredrik C Kugelberg
Journal:  Forensic Sci Med Pathol       Date:  2008-05-14       Impact factor: 2.007

Review 5.  Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.

Authors:  Jean Lud Cadet; Irina N Krasnova; Subramaniam Jayanthi; Johnalyn Lyles
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.